News + Font Resize -

Jaslok Hospital opts for Vercise System by Boston Scientific to treat Parkinson’s disease and dystonia
Our Bureau, Bengaluru | Friday, March 27, 2015, 13:30 Hrs  [IST]

Jaslok Hospital Mumbai has successfully implanted the most advanced ‘Deep Brain Stimulation’ system in two patients suffering from Parkinson’s disease and dystonia.  The technology offers significant improvement over previous DBS devices. Earlier the battery life was low and patients had to undergo repeated invasive surgeries for battery changes every 3-4 years. The new Vercise System by Boston Scientific has an extended battery life of up to 25 years.

DBS is a neurosurgical procedure that involves the implantation of a medical device called a brain pacemaker which sends electrical impulsesto specific parts of the brain for the treatment of tremor. Essential tremor can be very debilitating for patients in their day-to-day activities such as writing, eating or holding things.

“Remarkable improvement is already visible in our Parkinson’s disease patient post the deep brain stimulation procedure. The technology provides us with new stimulation options we have never had before. We are particularly pleased with the long battery life of the new DBS system offering a new lease of life to many patientsby eliminating the necessity of multiple surgeries. The advanced programming interface would reduce the side effects and improve the benefits of stimulation. Infact, we can now use DBS therapy in children as well, which was previously difficult.” said Dr. Paresh Doshi, director, neurosurgery and functional neurosurgery,  Jaslok Hospital.

The Vercise System by Boston Scientific is designed to provide comfort, control, and convenience to the clinician's practice and to patients. It is designed for precise neural targeting to customize therapy to patients.

“It is a significant development in movement disorder therapy for patients as well as doctors. With our team of experienced doctors and advanced  facilities, we hope to make a positive difference to patients  continuing to offer the most advanced therapies,” said Dr Tarang Gianchandani, CEO, Jaslok Hospital.

Post Your Comment

 

Enquiry Form